Swissmedic approves Norgine’s Ifinwil for children diagnosed with high-risk neuroblastoma: Uxbridge, UK Thursday, July 10, 2025, 17:00 Hrs [IST] Norgine, a leading European spec ...

Norgine, a leading European specialty pharmaceutical company, announced that Swissmedic has approved the registration of Ifinwil (eflornithine) as monotherapy for the treatment of paediatric patients ...

IFINWIL®: now approved in Switzerland1Nine out of 10 cases of neuroblastoma occur in children under the age of five2The average survival rate of children with HRNB is only 50%2UXBRIDGE, England ...

IFINWIL®: now approved in Switzerland1Nine out of 10 cases of neuroblastoma occur in children under the age of five2The ...

Essential Pharma has bought Renaissance Pharma, adding its first developmental drug candidate, a therapy for rare cancer neuroblastoma.

NICE has said EUSA Pharma’s Qarziba for the rare childhood cancer high-risk neuroblastoma should not get regular funding from the NHS – but could be given interim funding on the Cancer Drugs ...

Endocrine system articles from across Nature Portfolio The endocrine system refers to the cells, glands and organs that secrete hormones directly into the blood in order to control physiological ...